BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21545624)

  • 1. Reversible parkinsonism and cognitive decline due to a possible interaction of valproic acid and quetiapine.
    De Dios C; Fudio S; Lorenzo A
    J Clin Pharm Ther; 2011 Jun; 36(3):430-2. PubMed ID: 21545624
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neutropenia associated with the comedication of quetiapine and valproate in 2 elderly patients.
    Hung WC; Hsieh MH
    J Clin Psychopharmacol; 2012 Jun; 32(3):416-7. PubMed ID: 22561472
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperammonemia induced by interaction of valproate and quetiapine.
    Halaby A; Haddad R; Naja WJ
    Curr Drug Saf; 2013 Sep; 8(4):284-6. PubMed ID: 23962184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of quetiapine XR and divalproex-associated neutropenia followed by successful use of ziprasidone.
    Estabrook KR; Pheister M
    J Clin Psychopharmacol; 2012 Jun; 32(3):417-8. PubMed ID: 22561473
    [No Abstract]   [Full Text] [Related]  

  • 5. Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case report.
    Alvarez P; Papaseit E; Pérez V; Bulbena A; Farré M
    Actas Esp Psiquiatr; 2019 Jan; 47(1):33-6. PubMed ID: 30724329
    [No Abstract]   [Full Text] [Related]  

  • 6. Pedal edema associated with addition of low-dose quetiapine to valproate treatment in bipolar disorder.
    Chen CY; Yeh YW; Kuo SC; Shiah IS; Liu PY; Chen CL
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Nov; 33(8):1551-2. PubMed ID: 19665043
    [No Abstract]   [Full Text] [Related]  

  • 7. Quetiapine in the treatment of acute bipolar mania: efficacy across a broad range of symptoms.
    McIntyre RS; Konarski JZ; Jones M; Paulsson B
    J Affect Disord; 2007; 100 Suppl 1():S5-14. PubMed ID: 17391773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy and tolerability of quetiapine versus divalproex for the treatment of impulsivity and reactive aggression in adolescents with co-occurring bipolar disorder and disruptive behavior disorder(s).
    Barzman DH; DelBello MP; Adler CM; Stanford KE; Strakowski SM
    J Child Adolesc Psychopharmacol; 2006 Dec; 16(6):665-70. PubMed ID: 17201610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions between valproic acid and quetiapine/olanzapine in the treatment of bipolar disorder and the role of therapeutic drug monitoring.
    Vella T; Mifsud J
    J Pharm Pharmacol; 2014 Jun; 66(6):747-59. PubMed ID: 24392714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of remission/euthymia with quetiapine in combination with lithium/divalproex for the treatment of acute mania.
    Sussman N; Mullen J; Paulsson B; Vågerö M
    J Affect Disord; 2007; 100 Suppl 1():S55-63. PubMed ID: 17383736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unexpected interaction between quetiapine and valproate in patients with bipolar disorder.
    Huang CC; Wei IH
    Gen Hosp Psychiatry; 2010; 32(4):446.e1-2. PubMed ID: 20633751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination treatment with quetiapine in bipolar disorder patients.
    Basu D; Chakraborty K
    Am J Psychiatry; 2009 Oct; 166(10):1185; author reply 1186-7. PubMed ID: 19797447
    [No Abstract]   [Full Text] [Related]  

  • 13. Reversible Valproic Acid-Induced Parkinsonism and Cognitive Impairment in an Elderly Patient With Bipolar Disorder I.
    Hassamal S; Waller S; Reese K; Testa C
    Turk Psikiyatri Derg; 2016; 27(3):213-217. PubMed ID: 27711942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cervical dystonia due to interaction of valproic acid and quetiapine.
    Habermeyer B; Rabovsky K; Jentzsch C; Pinhard K; Müller-Spahn F
    J Clin Psychopharmacol; 2007 Aug; 27(4):396-7. PubMed ID: 17632227
    [No Abstract]   [Full Text] [Related]  

  • 15. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
    Winter HR; DeVane CL; Figueroa C; Ennis DJ; Hamer-Maansson JE; Davis PC; Smith MA
    Hum Psychopharmacol; 2007 Oct; 22(7):469-76. PubMed ID: 17729385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of quetiapine in the treatment of acute mania in bipolar disorder.
    Adler CM; Fleck DE; Brecher M; Strakowski SM
    J Affect Disord; 2007; 100 Suppl 1():S15-22. PubMed ID: 17383737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Monotherapy with lithium or valproate or respectively combination therapy with quetiapine have similar effect on cognitive functions in Chinese euthymic patients with bipolar disorder: a cross-sectional survey.
    Lin Y; Lin Y; Li X; Lao G; Jiang Z; Ye B; Lin W; Liu Y; Cao L
    J Clin Psychopharmacol; 2013 Dec; 33(6):817-9. PubMed ID: 23963059
    [No Abstract]   [Full Text] [Related]  

  • 18. Divalproex sodium and quetiapine treatment of a pedophile with bipolar spectrum disorder.
    Wang SC; Kao YC; Liu YP
    J Neuropsychiatry Clin Neurosci; 2014; 26(3):E47-8. PubMed ID: 25093789
    [No Abstract]   [Full Text] [Related]  

  • 19. Maintenance treatment for patients with bipolar I disorder: results from a north american study of quetiapine in combination with lithium or divalproex (trial 127).
    Suppes T; Vieta E; Liu S; Brecher M; Paulsson B;
    Am J Psychiatry; 2009 Apr; 166(4):476-88. PubMed ID: 19289454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double blind, randomized, placebo-controlled trial of quetiapine as an add-on therapy to lithium or divalproex for the treatment of bipolar mania.
    Yatham LN; Vieta E; Young AH; Möller HJ; Paulsson B; Vågerö M
    Int Clin Psychopharmacol; 2007 Jul; 22(4):212-20. PubMed ID: 17519644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.